skip to Main Content

Mission Statement

To accelerate haemato-oncology patient access to novel therapies, combinations and cellular therapies, and improve outcomes for patients. To attract, support and deliver research trials in the UK for patients with blood cancer.

Vision

  • Create a sustainable infrastructure to run haemato-oncology trials in the UK giving patients access to novel drug, stem cell transplant and cellular therapies
  • Generate practice changing quality data to benefit patients
  • Increase UK trial capacity to deliver pivotal blood cancer trials
  • Align with UK NIHR and NCRI strategy
  • Create an integrated trial proposition with the potential to increase the number of future trials of novel therapies
  • Empower and resource the current and next generation of clinical investigators and research nurses